These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 24780101

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Real-time assessment of granule densification in high shear wet granulation and application to scale-up of a placebo and a brivanib alaninate formulation.
    Narang AS, Sheverev VA, Stepaniuk V, Badawy S, Stevens T, Macias K, Wolf A, Pandey P, Bindra D, Varia S.
    J Pharm Sci; 2015 Mar; 104(3):1019-34. PubMed ID: 25470221
    [Abstract] [Full Text] [Related]

  • 5. Preclinical pharmacokinetics and in vitro metabolism of brivanib (BMS-540215), a potent VEGFR2 inhibitor and its alanine ester prodrug brivanib alaninate.
    Marathe PH, Kamath AV, Zhang Y, D'Arienzo C, Bhide R, Fargnoli J.
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):55-66. PubMed ID: 19396600
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Predicting drug hydrolysis based on moisture uptake in various packaging designs.
    Naversnik K, Bohanec S.
    Eur J Pharm Sci; 2008 Dec 18; 35(5):447-56. PubMed ID: 18940251
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acid-catalyzed hydrolysis of BMS-582664: degradation product identification and mechanism elucidation.
    Zhao F, Derbin G, Miller S, Badawy S, Hussain M.
    J Pharm Sci; 2012 Sep 18; 101(9):3526-30. PubMed ID: 22189636
    [Abstract] [Full Text] [Related]

  • 17. Quality by design approach for formulation development: a case study of dispersible tablets.
    Charoo NA, Shamsher AA, Zidan AS, Rahman Z.
    Int J Pharm; 2012 Feb 28; 423(2):167-78. PubMed ID: 22209997
    [Abstract] [Full Text] [Related]

  • 18. Metabolism and disposition of [14C]brivanib alaninate after oral administration to rats, monkeys, and humans.
    Gong J, Gan J, Caceres-Cortes J, Christopher LJ, Arora V, Masson E, Williams D, Pursley J, Allentoff A, Lago M, Tran SB, Iyer RA.
    Drug Metab Dispos; 2011 May 28; 39(5):891-903. PubMed ID: 21289073
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.